Aurinia Pharmaceuticals Inc

amr_youssef2

You can buy AUPH target 24 stop loss 17.39 Money management your responsibility. I recommend entering a maximum of 10% of the portfolio. Good luck

shkspr

NASDAQ:AUPH Possible Scenario: LONG Evidence: Price Action, I'm pretty sure about it, this is one of my main positions early morning. I expect it hit the Fibo level 100% at 25$ this week, most likely tomorrow Call options, strike 25$, 10/15/2021. *This is my idea and could be wrong 100%.

NinjaNew

Tons of money to played in this, constant up and down trend. Either short when it hits the channel trend line top, or go long at the channel bottom... I would rather be the bull in this situation though... so I would hold out on a entry.

stsoumpas

BULLISH WEDGE Been brewing since FDA approval of Voclosporin. Lots of reasons to speculate a buyout or possible merger with recent voluntary delisting from the TSX and remaining on NYSE. Excellent setup to be a cash cow. Target Price of $35 be EOY playing Oct Calls. PFE and MRNA are LOADED with cash and you know they're sniffing out opportunities and would love...

20:00

iCantw84it

This is a video I made to cover all the plays made about a month ago up until about two weeks ago. I cut off half way through and honestly I thought it didn't record any of it. So I am posting it now. and I will pick up where it left off probably tomorrow. If these have helped you trade please like and follow. by iCantw84it 05.26.2021

shkspr

NASDAQ:AUPH Possible Scenario: LONG Evidence: Price Action TP1~ 12.5$. TP2 ~14.25$ Call options, Strike 14$, 07/16/21 Call options, Strike 15$, 07/16/21 * This is my idea and could be wrong 100%

Brain_Storm1111

School of cumulative chaos measurements and waves 23.6

Brain_Storm1111

Transporter 23 Back support

04:57

daytraderrockstar

Its been a long time coming but I have identified a long term trend line that will be a great entry. Its here now and woth a entry. I will be adding on Monday

rbswingtrader

Given its recent FDA approvals ir.auriniapharma.com , we will see this breaking out in short time and head towards $30.

des

Spike from FDA approval. Anticipate pull back to 61 fib level. MT - price target is 61 feb extension level.

PlanTradePlanMM

Wedge breakout, revisit trendline ABC Patten: Swing A crossed SMA50 (1st) and SMA200 (2nd), Wave#1 Swing B tested SMA200 as support. Wave#2 Swing C will be not less than A; Wave#3 Entry 16 Stop 14 Target 22 I am not a PRO trader. I trade option to test my trading plan with small cost. The max Risk of each plan is less than 1% of my account. If you like this...

runNgun

Long on AUPH with entry around 15, just crossed over the 50ma on the 15m. Patients treated with LUPKYNIS plus SoC were more than twice as likely to achieve renal response (RR) and experienced a decline in urine protein creatinine ratio (UPCR) twice as fast as patients on typical SoC alone.

PennantTrading

Looking to break the downtrend. Could be a false breakout if it does.

manuchehr67

have problem with 22 resistance but if break 22 can go to dynamic resistance 34 or static 39. stop loss 12.5

NoahMogil

Long position ahead on open of FDA approval

Vibranium_Capital

nice pullback/consolidation here for auph, look for a big breakout over the blue resistance area, if that breaks we can hit 20+ in early 2021 in my opinion. you can enter early here 14.8 , stop loss 13 and target 20+! leave a like/follow if you enjoy my ideas <3

Mike_y

Year long pennant break out, should hit top of pennant within the next week ($22) then head toward $28